Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

34.29
Delayed Data
As of Aug 28
 -0.09 / -0.26%
Today’s Change
18.23
Today|||52-Week Range
42.48
+73.18%
Year-to-Date

Today’s Trading

Previous close34.38
Today’s open34.04
Day’s range33.21 - 34.54
Volume182,916
Average volume (3 months)345,310
Market cap$1.1B
Dividend yield--
Data as of 08/28/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+34.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio--
Price/Sales10.36
Price/Book10.06

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+1.31+4.60%
CLLSCellectis SA+0.51+1.56%
TXMDTherapeuticsMD Inc+0.17+2.85%
MACKMerrimack Pharmaceut...+0.07+0.67%
Data as of 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

Chart unavailable

Partner Offers